Ha H, Kim K H
Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J. 1992 Sep;33(3):217-23. doi: 10.3349/ymj.1992.33.3.217.
Administration of captopril, a scavenger of oxygen derived radicals as well as an inhibitor of angiotensin converting enzyme, has been an efficient way of treating diabetic proteinuria. In the present study, we evaluate whether captopril can ameliorate diabetic proteinuria as an effect on oxidative stress in streptozotocin- induced diabetic rats (STZR). At four weeks after the injection of streptozotocin (50 mg/kg, i.v.), STZR (n = 5) exhibited microalbuminuria. The rate of urinary albumin excretion was 0.5 +/- 0.1 and 2.6 +/- 0.3 mg/24hr in age-matched control rats (CR; n = 5) and STZR, respectively. Compared to CR, STZR also showed an extremely increased rate of urinary lipid peroxides (LPO) excretion, an index of oxygen derived radicals generation. The respective values for CR and STZR were 0.6 +/- 0.3 and 6.9 +/- 0.6 mumol/24 hr. Significant amelioration of urinary albumin and LPO excretion rate by the treatment of insulin (2 U/day) suggests that these are associated with the diabetic state induced by streptozotocin rather than a direct effect of streptozotocin. Chronic administration of captopril, which did not cause any discernible effect on CR, significantly reduced the urinary albumin excretion rate and decreased LPO excretion in STZR. The urinary albumin excretion rate was significantly correlated with the LPO excretion rate (p = 0.0004). These results suggest that oxidative stress can be responsible for diabetic microalbuminuria, and captopril could diminish the lipid peroxidation and ameliorate the microalbuminuria in diabetic rats.
卡托普利是一种氧自由基清除剂,也是一种血管紧张素转换酶抑制剂,它一直是治疗糖尿病蛋白尿的有效方法。在本研究中,我们评估卡托普利是否能通过对链脲佐菌素诱导的糖尿病大鼠(STZR)氧化应激的影响来改善糖尿病蛋白尿。在静脉注射链脲佐菌素(50mg/kg)四周后,STZR(n = 5)出现微量白蛋白尿。年龄匹配的对照大鼠(CR;n = 5)和STZR的尿白蛋白排泄率分别为0.5±0.1和2.6±0.3mg/24小时。与CR相比,STZR的尿脂质过氧化物(LPO)排泄率也显著增加,LPO是氧自由基生成的一个指标。CR和STZR的相应值分别为0.6±0.3和6.9±0.6μmol/24小时。胰岛素(2U/天)治疗可显著改善尿白蛋白和LPO排泄率,这表明这些与链脲佐菌素诱导的糖尿病状态有关,而不是链脲佐菌素的直接作用。长期给予卡托普利对CR没有任何明显影响,但能显著降低STZR的尿白蛋白排泄率并减少LPO排泄。尿白蛋白排泄率与LPO排泄率显著相关(p = 0.0004)。这些结果表明,氧化应激可能是糖尿病微量白蛋白尿的原因,卡托普利可以减少脂质过氧化并改善糖尿病大鼠的微量白蛋白尿。